English

ALLIANCE PHARMACEUTICAL CORP.

EDGAR

Quarterly report (10-Q) · filed 2010-06-04

68 filing records in this dataset, filed from 1995-02-10 to 2010-06-04. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Cash and cash equivalents: 100 thousand USD 2010-03-31 Source
Exact value

100000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

573 thousand USD

2009-04-01 – 2010-03-31

Exact inputs and evidence

Net income: -1203000 USD · 2008-07-01 – 2009-06-30 Source
Net income: -888000 USD · 2008-07-01 – 2009-03-31 Source
Net income: -328000 USD · 2009-07-01 – 2009-09-30 Source
Net income: 1390000 USD · 2009-10-01 – 2009-12-31 Source
Net income: -174000 USD · 2010-01-01 – 2010-03-31 Source

Operating cash flow

5 thousand USD

2009-04-01 – 2010-03-31

Exact inputs and evidence

Operating cash flow: 31000 USD · 2008-07-01 – 2009-06-30 Source
Operating cash flow: 86000 USD · 2008-07-01 – 2009-03-31 Source
Operating cash flow: -28000 USD · 2009-07-01 – 2009-09-30 Source
Operating cash flow: -41000 USD · 2009-07-01 – 2009-12-31 Source
Operating cash flow: -28000 USD · 2009-07-01 – 2009-09-30 Source
Operating cash flow: 60000 USD · 2009-07-01 – 2010-03-31 Source
Operating cash flow: -41000 USD · 2009-07-01 – 2009-12-31 Source

Capital expenditure

0 USD

2007-07-01 – 2008-06-30

Exact inputs and evidence

Capital expenditure: 0 USD · 2007-07-01 – 2007-09-30 Source
Capital expenditure: 0 USD · 2007-07-01 – 2007-12-31 Source
Capital expenditure: 0 USD · 2007-07-01 – 2007-09-30 Source
Capital expenditure: 0 USD · 2007-07-01 – 2008-03-31 Source
Capital expenditure: 0 USD · 2007-07-01 – 2007-12-31 Source
Capital expenditure: 0 USD · 2007-07-01 – 2008-06-30 Source
Capital expenditure: 0 USD · 2007-07-01 – 2008-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2010-06-04.

Financial data available through: 2009-06-30.

Coverage by financial measure

revenue: No compatible figures in this window
Operating income: 11 of 11 periods available· newest 2009-06-30
Net income: 11 of 11 periods available· newest 2009-06-30
Operating cash flow: 11 of 11 periods available· newest 2009-06-30
Capital expenditure: 10 of 11 periods available· newest 2008-06-30
assets: No compatible figures in this window
Total liabilities: 5 of 11 periods available· newest 2009-06-30
Current assets: 11 of 11 periods available· newest 2009-06-30
Current liabilities: 11 of 11 periods available· newest 2009-06-30
Cash and cash equivalents: 11 of 11 periods available· newest 2009-06-30
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
+USD 577,000

Prior period

−USD 1.78 million

2007-07-01 – 2008-06-30
Current period

−USD 1.2 million

2008-07-01 – 2009-06-30

Exact inputs and evidence

-1203000 − -1780000 = 577000 USD

-1780000 USD · 2007-07-01 – 2008-06-30
Inspect prior input Prior source
-1203000 USD · 2008-07-01 – 2009-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · ALLIANCE PHARMACEUTICAL CORP. · 2009-06-30 ALLIANCE PHARMACEUTICAL CORP. (edgar:736994) Year-over-year change in Net income: 577000 USD Concept: fundies:NetIncome Period: 2008-07-01 to 2009-06-30 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 6e48cb0be5d9575d2554fd60dbaa21a5c42a4f9600280aff0f4b9cbb3bef2770 Dimensions: Consolidated View: https://fundies.io/companies/edgar/736994?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -1203000 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001019687-10-001960.txt#4560 Input fundies:NetIncome: -1780000 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001019687-10-001960.txt#4560
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 899,000

Prior period

−USD 868,000

2007-07-01 – 2008-06-30
Current period

USD 31,000

2008-07-01 – 2009-06-30

Exact inputs and evidence

31000 − -868000 = 899000 USD

-868000 USD · 2007-07-01 – 2008-06-30
Inspect prior input Prior source
31000 USD · 2008-07-01 – 2009-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · ALLIANCE PHARMACEUTICAL CORP. · 2009-06-30 ALLIANCE PHARMACEUTICAL CORP. (edgar:736994) Year-over-year change in Operating cash flow: 899000 USD Concept: fundies:OperatingCashFlow Period: 2008-07-01 to 2009-06-30 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 6e48cb0be5d9575d2554fd60dbaa21a5c42a4f9600280aff0f4b9cbb3bef2770 Dimensions: Consolidated View: https://fundies.io/companies/edgar/736994?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 31000 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001019687-10-001960.txt#4680 Input fundies:OperatingCashFlow: -868000 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001019687-10-001960.txt#4680
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.

Values and sources

Revenue values and source evidence
Period	Series	Value	Source evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value	Source evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2000 1999-07-01 – 2000-06-30	−USD 46.47 million Exact value Exact value: -46467000 USD 1999-07-01 – 2000-06-30: -46467000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALLIANCE PHARMACEUTICAL CORP. · 2000-06-30 ALLIANCE PHARMACEUTICAL CORP. (edgar:736994) Net Income: -46467000 USD Concept: fundies:NetIncome Period: 1999-07-01 to 2000-06-30 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 6e48cb0be5d9575d2554fd60dbaa21a5c42a4f9600280aff0f4b9cbb3bef2770 Dimensions: Consolidated View: https://fundies.io/companies/edgar/736994/explain?concept=fundies%3ANetIncome&period=2000-06-30&surface=latest&period_type=duration&start=1999-07-01&unit=USD&dimensions= Input fundies:NetIncome: -46467000 USD (1999-07-01 to 2000-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0000912057-02-037231.txt#4151 The citation records this snapshot. The page link may show a newer release later.	−USD 26.95 million Exact value Exact value: -26948000 USD 1999-07-01 – 2000-06-30: -26948000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALLIANCE PHARMACEUTICAL CORP. · 2000-06-30 ALLIANCE PHARMACEUTICAL CORP. (edgar:736994) Operating Cash Flow: -26948000 USD Concept: fundies:OperatingCashFlow Period: 1999-07-01 to 2000-06-30 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 6e48cb0be5d9575d2554fd60dbaa21a5c42a4f9600280aff0f4b9cbb3bef2770 Dimensions: Consolidated View: https://fundies.io/companies/edgar/736994/explain?concept=fundies%3AOperatingCashFlow&period=2000-06-30&surface=latest&period_type=duration&start=1999-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -26948000 USD (1999-07-01 to 2000-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0000912057-02-037231.txt#4388 The citation records this snapshot. The page link may show a newer release later.	USD 736,000 Exact value Exact value: 736000 USD 1999-07-01 – 2000-06-30: 736000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALLIANCE PHARMACEUTICAL CORP. · 2000-06-30 ALLIANCE PHARMACEUTICAL CORP. (edgar:736994) Capital Expenditure: 736000 USD Concept: fundies:CapitalExpenditure Period: 1999-07-01 to 2000-06-30 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 6e48cb0be5d9575d2554fd60dbaa21a5c42a4f9600280aff0f4b9cbb3bef2770 Dimensions: Consolidated View: https://fundies.io/companies/edgar/736994/explain?concept=fundies%3ACapitalExpenditure&period=2000-06-30&surface=latest&period_type=duration&start=1999-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 736000 USD (1999-07-01 to 2000-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0000912057-02-037231.txt#4452 The citation records this snapshot. The page link may show a newer release later.	−USD 27.68 million Calculation and evidence -26948000 − 736000 USD Exact free cash flow: -27684000 USD 1999-07-01 – 2000-06-30: -26948000 USD · Inspect Operating Cash Flow · Source 1999-07-01 – 2000-06-30: 736000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALLIANCE PHARMACEUTICAL CORP. · 2000-06-30 ALLIANCE PHARMACEUTICAL CORP. (edgar:736994) Free cash flow: -27684000 USD Concept: free-cash-flow Period: 1999-07-01 to 2000-06-30 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 6e48cb0be5d9575d2554fd60dbaa21a5c42a4f9600280aff0f4b9cbb3bef2770 Dimensions: Consolidated View: https://fundies.io/companies/edgar/736994?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -26948000 USD (1999-07-01 to 2000-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0000912057-02-037231.txt#4388 Input fundies:CapitalExpenditure: 736000 USD (1999-07-01 to 2000-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0000912057-02-037231.txt#4452 The citation records this snapshot. The page link may show a newer release later.
2001 2000-07-01 – 2001-06-30	−USD 60.68 million Exact value Exact value: -60676000 USD 2000-07-01 – 2001-06-30: -60676000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALLIANCE PHARMACEUTICAL CORP. · 2001-06-30 ALLIANCE PHARMACEUTICAL CORP. (edgar:736994) Net Income: -60676000 USD Concept: fundies:NetIncome Period: 2000-07-01 to 2001-06-30 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 6e48cb0be5d9575d2554fd60dbaa21a5c42a4f9600280aff0f4b9cbb3bef2770 Dimensions: Consolidated View: https://fundies.io/companies/edgar/736994/explain?concept=fundies%3ANetIncome&period=2001-06-30&surface=latest&period_type=duration&start=2000-07-01&unit=USD&dimensions= Input fundies:NetIncome: -60676000 USD (2000-07-01 to 2001-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001206774-03-000761.txt#2496 The citation records this snapshot. The page link may show a newer release later.	−USD 57.55 million Exact value Exact value: -57554000 USD 2000-07-01 – 2001-06-30: -57554000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALLIANCE PHARMACEUTICAL CORP. · 2001-06-30 ALLIANCE PHARMACEUTICAL CORP. (edgar:736994) Operating Cash Flow: -57554000 USD Concept: fundies:OperatingCashFlow Period: 2000-07-01 to 2001-06-30 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 6e48cb0be5d9575d2554fd60dbaa21a5c42a4f9600280aff0f4b9cbb3bef2770 Dimensions: Consolidated View: https://fundies.io/companies/edgar/736994/explain?concept=fundies%3AOperatingCashFlow&period=2001-06-30&surface=latest&period_type=duration&start=2000-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -57554000 USD (2000-07-01 to 2001-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001206774-03-000761.txt#2512 The citation records this snapshot. The page link may show a newer release later.	USD 2.75 million Exact value Exact value: 2747000 USD 2000-07-01 – 2001-06-30: 2747000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALLIANCE PHARMACEUTICAL CORP. · 2001-06-30 ALLIANCE PHARMACEUTICAL CORP. (edgar:736994) Capital Expenditure: 2747000 USD Concept: fundies:CapitalExpenditure Period: 2000-07-01 to 2001-06-30 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 6e48cb0be5d9575d2554fd60dbaa21a5c42a4f9600280aff0f4b9cbb3bef2770 Dimensions: Consolidated View: https://fundies.io/companies/edgar/736994/explain?concept=fundies%3ACapitalExpenditure&period=2001-06-30&surface=latest&period_type=duration&start=2000-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2747000 USD (2000-07-01 to 2001-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001206774-03-000761.txt#2517 The citation records this snapshot. The page link may show a newer release later.	−USD 60.3 million Calculation and evidence -57554000 − 2747000 USD Exact free cash flow: -60301000 USD 2000-07-01 – 2001-06-30: -57554000 USD · Inspect Operating Cash Flow · Source 2000-07-01 – 2001-06-30: 2747000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALLIANCE PHARMACEUTICAL CORP. · 2001-06-30 ALLIANCE PHARMACEUTICAL CORP. (edgar:736994) Free cash flow: -60301000 USD Concept: free-cash-flow Period: 2000-07-01 to 2001-06-30 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 6e48cb0be5d9575d2554fd60dbaa21a5c42a4f9600280aff0f4b9cbb3bef2770 Dimensions: Consolidated View: https://fundies.io/companies/edgar/736994?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -57554000 USD (2000-07-01 to 2001-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001206774-03-000761.txt#2512 Input fundies:CapitalExpenditure: 2747000 USD (2000-07-01 to 2001-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001206774-03-000761.txt#2517 The citation records this snapshot. The page link may show a newer release later.
2002 2001-07-01 – 2002-06-30	−USD 34.23 million Exact value Exact value: -34227000 USD 2001-07-01 – 2002-06-30: -34227000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALLIANCE PHARMACEUTICAL CORP. · 2002-06-30 ALLIANCE PHARMACEUTICAL CORP. (edgar:736994) Net Income: -34227000 USD Concept: fundies:NetIncome Period: 2001-07-01 to 2002-06-30 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 6e48cb0be5d9575d2554fd60dbaa21a5c42a4f9600280aff0f4b9cbb3bef2770 Dimensions: Consolidated View: https://fundies.io/companies/edgar/736994/explain?concept=fundies%3ANetIncome&period=2002-06-30&surface=latest&period_type=duration&start=2001-07-01&unit=USD&dimensions= Input fundies:NetIncome: -34227000 USD (2001-07-01 to 2002-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001206774-03-000761.txt#2496 The citation records this snapshot. The page link may show a newer release later.	−USD 21.44 million Exact value Exact value: -21441000 USD 2001-07-01 – 2002-06-30: -21441000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALLIANCE PHARMACEUTICAL CORP. · 2002-06-30 ALLIANCE PHARMACEUTICAL CORP. (edgar:736994) Operating Cash Flow: -21441000 USD Concept: fundies:OperatingCashFlow Period: 2001-07-01 to 2002-06-30 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 6e48cb0be5d9575d2554fd60dbaa21a5c42a4f9600280aff0f4b9cbb3bef2770 Dimensions: Consolidated View: https://fundies.io/companies/edgar/736994/explain?concept=fundies%3AOperatingCashFlow&period=2002-06-30&surface=latest&period_type=duration&start=2001-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -21441000 USD (2001-07-01 to 2002-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001206774-03-000761.txt#2512 The citation records this snapshot. The page link may show a newer release later.	USD 65,000 Exact value Exact value: 65000 USD 2001-07-01 – 2002-06-30: 65000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALLIANCE PHARMACEUTICAL CORP. · 2002-06-30 ALLIANCE PHARMACEUTICAL CORP. (edgar:736994) Capital Expenditure: 65000 USD Concept: fundies:CapitalExpenditure Period: 2001-07-01 to 2002-06-30 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 6e48cb0be5d9575d2554fd60dbaa21a5c42a4f9600280aff0f4b9cbb3bef2770 Dimensions: Consolidated View: https://fundies.io/companies/edgar/736994/explain?concept=fundies%3ACapitalExpenditure&period=2002-06-30&surface=latest&period_type=duration&start=2001-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 65000 USD (2001-07-01 to 2002-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001206774-03-000761.txt#2517 The citation records this snapshot. The page link may show a newer release later.	−USD 21.51 million Calculation and evidence -21441000 − 65000 USD Exact free cash flow: -21506000 USD 2001-07-01 – 2002-06-30: -21441000 USD · Inspect Operating Cash Flow · Source 2001-07-01 – 2002-06-30: 65000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALLIANCE PHARMACEUTICAL CORP. · 2002-06-30 ALLIANCE PHARMACEUTICAL CORP. (edgar:736994) Free cash flow: -21506000 USD Concept: free-cash-flow Period: 2001-07-01 to 2002-06-30 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 6e48cb0be5d9575d2554fd60dbaa21a5c42a4f9600280aff0f4b9cbb3bef2770 Dimensions: Consolidated View: https://fundies.io/companies/edgar/736994?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -21441000 USD (2001-07-01 to 2002-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001206774-03-000761.txt#2512 Input fundies:CapitalExpenditure: 65000 USD (2001-07-01 to 2002-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001206774-03-000761.txt#2517 The citation records this snapshot. The page link may show a newer release later.
2003 2002-07-01 – 2003-06-30	−USD 20.32 million Exact value Exact value: -20324000 USD 2002-07-01 – 2003-06-30: -20324000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALLIANCE PHARMACEUTICAL CORP. · 2003-06-30 ALLIANCE PHARMACEUTICAL CORP. (edgar:736994) Net Income: -20324000 USD Concept: fundies:NetIncome Period: 2002-07-01 to 2003-06-30 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 6e48cb0be5d9575d2554fd60dbaa21a5c42a4f9600280aff0f4b9cbb3bef2770 Dimensions: Consolidated View: https://fundies.io/companies/edgar/736994/explain?concept=fundies%3ANetIncome&period=2003-06-30&surface=latest&period_type=duration&start=2002-07-01&unit=USD&dimensions= Input fundies:NetIncome: -20324000 USD (2002-07-01 to 2003-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0000897069-04-001736.txt#4374 The citation records this snapshot. The page link may show a newer release later.	−USD 12.55 million Exact value Exact value: -12549000 USD 2002-07-01 – 2003-06-30: -12549000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALLIANCE PHARMACEUTICAL CORP. · 2003-06-30 ALLIANCE PHARMACEUTICAL CORP. (edgar:736994) Operating Cash Flow: -12549000 USD Concept: fundies:OperatingCashFlow Period: 2002-07-01 to 2003-06-30 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 6e48cb0be5d9575d2554fd60dbaa21a5c42a4f9600280aff0f4b9cbb3bef2770 Dimensions: Consolidated View: https://fundies.io/companies/edgar/736994/explain?concept=fundies%3AOperatingCashFlow&period=2003-06-30&surface=latest&period_type=duration&start=2002-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -12549000 USD (2002-07-01 to 2003-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0000897069-04-001736.txt#4438 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2002-07-01 – 2003-06-30: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALLIANCE PHARMACEUTICAL CORP. · 2003-06-30 ALLIANCE PHARMACEUTICAL CORP. (edgar:736994) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2002-07-01 to 2003-06-30 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 6e48cb0be5d9575d2554fd60dbaa21a5c42a4f9600280aff0f4b9cbb3bef2770 Dimensions: Consolidated View: https://fundies.io/companies/edgar/736994/explain?concept=fundies%3ACapitalExpenditure&period=2003-06-30&surface=latest&period_type=duration&start=2002-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2002-07-01 to 2003-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0000897069-04-001736.txt#4446 The citation records this snapshot. The page link may show a newer release later.	−USD 12.55 million Calculation and evidence -12549000 − 0 USD Exact free cash flow: -12549000 USD 2002-07-01 – 2003-06-30: -12549000 USD · Inspect Operating Cash Flow · Source 2002-07-01 – 2003-06-30: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALLIANCE PHARMACEUTICAL CORP. · 2003-06-30 ALLIANCE PHARMACEUTICAL CORP. (edgar:736994) Free cash flow: -12549000 USD Concept: free-cash-flow Period: 2002-07-01 to 2003-06-30 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 6e48cb0be5d9575d2554fd60dbaa21a5c42a4f9600280aff0f4b9cbb3bef2770 Dimensions: Consolidated View: https://fundies.io/companies/edgar/736994?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -12549000 USD (2002-07-01 to 2003-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0000897069-04-001736.txt#4438 Input fundies:CapitalExpenditure: 0 USD (2002-07-01 to 2003-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0000897069-04-001736.txt#4446 The citation records this snapshot. The page link may show a newer release later.
2004 2003-07-01 – 2004-06-30	USD 10.02 million Exact value Exact value: 10016000 USD 2003-07-01 – 2004-06-30: 10016000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALLIANCE PHARMACEUTICAL CORP. · 2004-06-30 ALLIANCE PHARMACEUTICAL CORP. (edgar:736994) Net Income: 10016000 USD Concept: fundies:NetIncome Period: 2003-07-01 to 2004-06-30 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 6e48cb0be5d9575d2554fd60dbaa21a5c42a4f9600280aff0f4b9cbb3bef2770 Dimensions: Consolidated View: https://fundies.io/companies/edgar/736994/explain?concept=fundies%3ANetIncome&period=2004-06-30&surface=latest&period_type=duration&start=2003-07-01&unit=USD&dimensions= Input fundies:NetIncome: 10016000 USD (2003-07-01 to 2004-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001019687-05-002697.txt#2488 The citation records this snapshot. The page link may show a newer release later.	−USD 3.41 million Exact value Exact value: -3410000 USD 2003-07-01 – 2004-06-30: -3410000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALLIANCE PHARMACEUTICAL CORP. · 2004-06-30 ALLIANCE PHARMACEUTICAL CORP. (edgar:736994) Operating Cash Flow: -3410000 USD Concept: fundies:OperatingCashFlow Period: 2003-07-01 to 2004-06-30 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 6e48cb0be5d9575d2554fd60dbaa21a5c42a4f9600280aff0f4b9cbb3bef2770 Dimensions: Consolidated View: https://fundies.io/companies/edgar/736994/explain?concept=fundies%3AOperatingCashFlow&period=2004-06-30&surface=latest&period_type=duration&start=2003-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3410000 USD (2003-07-01 to 2004-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001019687-05-002697.txt#2500 The citation records this snapshot. The page link may show a newer release later.	USD 46,000 Exact value Exact value: 46000 USD 2003-07-01 – 2004-06-30: 46000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALLIANCE PHARMACEUTICAL CORP. · 2004-06-30 ALLIANCE PHARMACEUTICAL CORP. (edgar:736994) Capital Expenditure: 46000 USD Concept: fundies:CapitalExpenditure Period: 2003-07-01 to 2004-06-30 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 6e48cb0be5d9575d2554fd60dbaa21a5c42a4f9600280aff0f4b9cbb3bef2770 Dimensions: Consolidated View: https://fundies.io/companies/edgar/736994/explain?concept=fundies%3ACapitalExpenditure&period=2004-06-30&surface=latest&period_type=duration&start=2003-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 46000 USD (2003-07-01 to 2004-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001019687-05-002697.txt#2503 The citation records this snapshot. The page link may show a newer release later.	−USD 3.46 million Calculation and evidence -3410000 − 46000 USD Exact free cash flow: -3456000 USD 2003-07-01 – 2004-06-30: -3410000 USD · Inspect Operating Cash Flow · Source 2003-07-01 – 2004-06-30: 46000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALLIANCE PHARMACEUTICAL CORP. · 2004-06-30 ALLIANCE PHARMACEUTICAL CORP. (edgar:736994) Free cash flow: -3456000 USD Concept: free-cash-flow Period: 2003-07-01 to 2004-06-30 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 6e48cb0be5d9575d2554fd60dbaa21a5c42a4f9600280aff0f4b9cbb3bef2770 Dimensions: Consolidated View: https://fundies.io/companies/edgar/736994?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3410000 USD (2003-07-01 to 2004-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001019687-05-002697.txt#2500 Input fundies:CapitalExpenditure: 46000 USD (2003-07-01 to 2004-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001019687-05-002697.txt#2503 The citation records this snapshot. The page link may show a newer release later.
2005 2004-07-01 – 2005-06-30	−USD 5.74 million Exact value Exact value: -5743000 USD 2004-07-01 – 2005-06-30: -5743000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALLIANCE PHARMACEUTICAL CORP. · 2005-06-30 ALLIANCE PHARMACEUTICAL CORP. (edgar:736994) Net Income: -5743000 USD Concept: fundies:NetIncome Period: 2004-07-01 to 2005-06-30 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 6e48cb0be5d9575d2554fd60dbaa21a5c42a4f9600280aff0f4b9cbb3bef2770 Dimensions: Consolidated View: https://fundies.io/companies/edgar/736994/explain?concept=fundies%3ANetIncome&period=2005-06-30&surface=latest&period_type=duration&start=2004-07-01&unit=USD&dimensions= Input fundies:NetIncome: -5743000 USD (2004-07-01 to 2005-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001019687-06-002248.txt#2300 The citation records this snapshot. The page link may show a newer release later.	−USD 1.72 million Exact value Exact value: -1716000 USD 2004-07-01 – 2005-06-30: -1716000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALLIANCE PHARMACEUTICAL CORP. · 2005-06-30 ALLIANCE PHARMACEUTICAL CORP. (edgar:736994) Operating Cash Flow: -1716000 USD Concept: fundies:OperatingCashFlow Period: 2004-07-01 to 2005-06-30 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 6e48cb0be5d9575d2554fd60dbaa21a5c42a4f9600280aff0f4b9cbb3bef2770 Dimensions: Consolidated View: https://fundies.io/companies/edgar/736994/explain?concept=fundies%3AOperatingCashFlow&period=2005-06-30&surface=latest&period_type=duration&start=2004-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1716000 USD (2004-07-01 to 2005-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001019687-06-002248.txt#2314 The citation records this snapshot. The page link may show a newer release later.	USD 59,000 Exact value Exact value: 59000 USD 2004-07-01 – 2005-06-30: 59000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALLIANCE PHARMACEUTICAL CORP. · 2005-06-30 ALLIANCE PHARMACEUTICAL CORP. (edgar:736994) Capital Expenditure: 59000 USD Concept: fundies:CapitalExpenditure Period: 2004-07-01 to 2005-06-30 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 6e48cb0be5d9575d2554fd60dbaa21a5c42a4f9600280aff0f4b9cbb3bef2770 Dimensions: Consolidated View: https://fundies.io/companies/edgar/736994/explain?concept=fundies%3ACapitalExpenditure&period=2005-06-30&surface=latest&period_type=duration&start=2004-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 59000 USD (2004-07-01 to 2005-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001019687-06-002248.txt#2318 The citation records this snapshot. The page link may show a newer release later.	−USD 1.78 million Calculation and evidence -1716000 − 59000 USD Exact free cash flow: -1775000 USD 2004-07-01 – 2005-06-30: -1716000 USD · Inspect Operating Cash Flow · Source 2004-07-01 – 2005-06-30: 59000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALLIANCE PHARMACEUTICAL CORP. · 2005-06-30 ALLIANCE PHARMACEUTICAL CORP. (edgar:736994) Free cash flow: -1775000 USD Concept: free-cash-flow Period: 2004-07-01 to 2005-06-30 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 6e48cb0be5d9575d2554fd60dbaa21a5c42a4f9600280aff0f4b9cbb3bef2770 Dimensions: Consolidated View: https://fundies.io/companies/edgar/736994?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1716000 USD (2004-07-01 to 2005-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001019687-06-002248.txt#2314 Input fundies:CapitalExpenditure: 59000 USD (2004-07-01 to 2005-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001019687-06-002248.txt#2318 The citation records this snapshot. The page link may show a newer release later.
2006 2005-07-01 – 2006-06-30	−USD 9.58 million Exact value Exact value: -9575000 USD 2005-07-01 – 2006-06-30: -9575000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALLIANCE PHARMACEUTICAL CORP. · 2006-06-30 ALLIANCE PHARMACEUTICAL CORP. (edgar:736994) Net Income: -9575000 USD Concept: fundies:NetIncome Period: 2005-07-01 to 2006-06-30 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 6e48cb0be5d9575d2554fd60dbaa21a5c42a4f9600280aff0f4b9cbb3bef2770 Dimensions: Consolidated View: https://fundies.io/companies/edgar/736994/explain?concept=fundies%3ANetIncome&period=2006-06-30&surface=latest&period_type=duration&start=2005-07-01&unit=USD&dimensions= Input fundies:NetIncome: -9575000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001019687-07-003232.txt#2266 The citation records this snapshot. The page link may show a newer release later.	−USD 3.32 million Exact value Exact value: -3324000 USD 2005-07-01 – 2006-06-30: -3324000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALLIANCE PHARMACEUTICAL CORP. · 2006-06-30 ALLIANCE PHARMACEUTICAL CORP. (edgar:736994) Operating Cash Flow: -3324000 USD Concept: fundies:OperatingCashFlow Period: 2005-07-01 to 2006-06-30 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 6e48cb0be5d9575d2554fd60dbaa21a5c42a4f9600280aff0f4b9cbb3bef2770 Dimensions: Consolidated View: https://fundies.io/companies/edgar/736994/explain?concept=fundies%3AOperatingCashFlow&period=2006-06-30&surface=latest&period_type=duration&start=2005-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3324000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001019687-07-003232.txt#2280 The citation records this snapshot. The page link may show a newer release later.	USD 15,000 Exact value Exact value: 15000 USD 2005-07-01 – 2006-06-30: 15000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALLIANCE PHARMACEUTICAL CORP. · 2006-06-30 ALLIANCE PHARMACEUTICAL CORP. (edgar:736994) Capital Expenditure: 15000 USD Concept: fundies:CapitalExpenditure Period: 2005-07-01 to 2006-06-30 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 6e48cb0be5d9575d2554fd60dbaa21a5c42a4f9600280aff0f4b9cbb3bef2770 Dimensions: Consolidated View: https://fundies.io/companies/edgar/736994/explain?concept=fundies%3ACapitalExpenditure&period=2006-06-30&surface=latest&period_type=duration&start=2005-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 15000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001019687-07-003232.txt#2284 The citation records this snapshot. The page link may show a newer release later.	−USD 3.34 million Calculation and evidence -3324000 − 15000 USD Exact free cash flow: -3339000 USD 2005-07-01 – 2006-06-30: -3324000 USD · Inspect Operating Cash Flow · Source 2005-07-01 – 2006-06-30: 15000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALLIANCE PHARMACEUTICAL CORP. · 2006-06-30 ALLIANCE PHARMACEUTICAL CORP. (edgar:736994) Free cash flow: -3339000 USD Concept: free-cash-flow Period: 2005-07-01 to 2006-06-30 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 6e48cb0be5d9575d2554fd60dbaa21a5c42a4f9600280aff0f4b9cbb3bef2770 Dimensions: Consolidated View: https://fundies.io/companies/edgar/736994?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3324000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001019687-07-003232.txt#2280 Input fundies:CapitalExpenditure: 15000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001019687-07-003232.txt#2284 The citation records this snapshot. The page link may show a newer release later.
2007 2006-07-01 – 2007-06-30	−USD 4.09 million Exact value Exact value: -4093000 USD 2006-07-01 – 2007-06-30: -4093000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALLIANCE PHARMACEUTICAL CORP. · 2007-06-30 ALLIANCE PHARMACEUTICAL CORP. (edgar:736994) Net Income: -4093000 USD Concept: fundies:NetIncome Period: 2006-07-01 to 2007-06-30 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 6e48cb0be5d9575d2554fd60dbaa21a5c42a4f9600280aff0f4b9cbb3bef2770 Dimensions: Consolidated View: https://fundies.io/companies/edgar/736994/explain?concept=fundies%3ANetIncome&period=2007-06-30&surface=latest&period_type=duration&start=2006-07-01&unit=USD&dimensions= Input fundies:NetIncome: -4093000 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001019687-08-004413.txt#2336 The citation records this snapshot. The page link may show a newer release later.	−USD 2.8 million Exact value Exact value: -2796000 USD 2006-07-01 – 2007-06-30: -2796000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALLIANCE PHARMACEUTICAL CORP. · 2007-06-30 ALLIANCE PHARMACEUTICAL CORP. (edgar:736994) Operating Cash Flow: -2796000 USD Concept: fundies:OperatingCashFlow Period: 2006-07-01 to 2007-06-30 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 6e48cb0be5d9575d2554fd60dbaa21a5c42a4f9600280aff0f4b9cbb3bef2770 Dimensions: Consolidated View: https://fundies.io/companies/edgar/736994/explain?concept=fundies%3AOperatingCashFlow&period=2007-06-30&surface=latest&period_type=duration&start=2006-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2796000 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001019687-08-004413.txt#2349 The citation records this snapshot. The page link may show a newer release later.	USD 74,000 Exact value Exact value: 74000 USD 2006-07-01 – 2007-06-30: 74000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALLIANCE PHARMACEUTICAL CORP. · 2007-06-30 ALLIANCE PHARMACEUTICAL CORP. (edgar:736994) Capital Expenditure: 74000 USD Concept: fundies:CapitalExpenditure Period: 2006-07-01 to 2007-06-30 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 6e48cb0be5d9575d2554fd60dbaa21a5c42a4f9600280aff0f4b9cbb3bef2770 Dimensions: Consolidated View: https://fundies.io/companies/edgar/736994/explain?concept=fundies%3ACapitalExpenditure&period=2007-06-30&surface=latest&period_type=duration&start=2006-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 74000 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001019687-08-004413.txt#2353 The citation records this snapshot. The page link may show a newer release later.	−USD 2.87 million Calculation and evidence -2796000 − 74000 USD Exact free cash flow: -2870000 USD 2006-07-01 – 2007-06-30: -2796000 USD · Inspect Operating Cash Flow · Source 2006-07-01 – 2007-06-30: 74000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALLIANCE PHARMACEUTICAL CORP. · 2007-06-30 ALLIANCE PHARMACEUTICAL CORP. (edgar:736994) Free cash flow: -2870000 USD Concept: free-cash-flow Period: 2006-07-01 to 2007-06-30 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 6e48cb0be5d9575d2554fd60dbaa21a5c42a4f9600280aff0f4b9cbb3bef2770 Dimensions: Consolidated View: https://fundies.io/companies/edgar/736994?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2796000 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001019687-08-004413.txt#2349 Input fundies:CapitalExpenditure: 74000 USD (2006-07-01 to 2007-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001019687-08-004413.txt#2353 The citation records this snapshot. The page link may show a newer release later.
2008 2007-07-01 – 2008-06-30	−USD 1.78 million Exact value Exact value: -1780000 USD 2007-07-01 – 2008-06-30: -1780000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALLIANCE PHARMACEUTICAL CORP. · 2008-06-30 ALLIANCE PHARMACEUTICAL CORP. (edgar:736994) Net Income: -1780000 USD Concept: fundies:NetIncome Period: 2007-07-01 to 2008-06-30 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 6e48cb0be5d9575d2554fd60dbaa21a5c42a4f9600280aff0f4b9cbb3bef2770 Dimensions: Consolidated View: https://fundies.io/companies/edgar/736994/explain?concept=fundies%3ANetIncome&period=2008-06-30&surface=latest&period_type=duration&start=2007-07-01&unit=USD&dimensions= Input fundies:NetIncome: -1780000 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001019687-10-001960.txt#4560 The citation records this snapshot. The page link may show a newer release later.	−USD 868,000 Exact value Exact value: -868000 USD 2007-07-01 – 2008-06-30: -868000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALLIANCE PHARMACEUTICAL CORP. · 2008-06-30 ALLIANCE PHARMACEUTICAL CORP. (edgar:736994) Operating Cash Flow: -868000 USD Concept: fundies:OperatingCashFlow Period: 2007-07-01 to 2008-06-30 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 6e48cb0be5d9575d2554fd60dbaa21a5c42a4f9600280aff0f4b9cbb3bef2770 Dimensions: Consolidated View: https://fundies.io/companies/edgar/736994/explain?concept=fundies%3AOperatingCashFlow&period=2008-06-30&surface=latest&period_type=duration&start=2007-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -868000 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001019687-10-001960.txt#4680 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2007-07-01 – 2008-06-30: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ALLIANCE PHARMACEUTICAL CORP. · 2008-06-30 ALLIANCE PHARMACEUTICAL CORP. (edgar:736994) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2007-07-01 to 2008-06-30 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 6e48cb0be5d9575d2554fd60dbaa21a5c42a4f9600280aff0f4b9cbb3bef2770 Dimensions: Consolidated View: https://fundies.io/companies/edgar/736994/explain?concept=fundies%3ACapitalExpenditure&period=2008-06-30&surface=latest&period_type=duration&start=2007-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001019687-08-004413.txt#2353 The citation records this snapshot. The page link may show a newer release later.	−USD 868,000 Calculation and evidence -868000 − 0 USD Exact free cash flow: -868000 USD 2007-07-01 – 2008-06-30: -868000 USD · Inspect Operating Cash Flow · Source 2007-07-01 – 2008-06-30: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ALLIANCE PHARMACEUTICAL CORP. · 2008-06-30 ALLIANCE PHARMACEUTICAL CORP. (edgar:736994) Free cash flow: -868000 USD Concept: free-cash-flow Period: 2007-07-01 to 2008-06-30 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 6e48cb0be5d9575d2554fd60dbaa21a5c42a4f9600280aff0f4b9cbb3bef2770 Dimensions: Consolidated View: https://fundies.io/companies/edgar/736994?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -868000 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001019687-10-001960.txt#4680 Input fundies:CapitalExpenditure: 0 USD (2007-07-01 to 2008-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001019687-08-004413.txt#2353 The citation records this snapshot. The page link may show a newer release later.
2009 2008-07-01 – 2009-06-30	−USD 1.2 million Exact value Exact value: -1203000 USD 2008-07-01 – 2009-06-30: -1203000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ALLIANCE PHARMACEUTICAL CORP. · 2009-06-30 ALLIANCE PHARMACEUTICAL CORP. (edgar:736994) Net Income: -1203000 USD Concept: fundies:NetIncome Period: 2008-07-01 to 2009-06-30 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 6e48cb0be5d9575d2554fd60dbaa21a5c42a4f9600280aff0f4b9cbb3bef2770 Dimensions: Consolidated View: https://fundies.io/companies/edgar/736994/explain?concept=fundies%3ANetIncome&period=2009-06-30&surface=latest&period_type=duration&start=2008-07-01&unit=USD&dimensions= Input fundies:NetIncome: -1203000 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001019687-10-001960.txt#4560 The citation records this snapshot. The page link may show a newer release later.	USD 31,000 Exact value Exact value: 31000 USD 2008-07-01 – 2009-06-30: 31000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ALLIANCE PHARMACEUTICAL CORP. · 2009-06-30 ALLIANCE PHARMACEUTICAL CORP. (edgar:736994) Operating Cash Flow: 31000 USD Concept: fundies:OperatingCashFlow Period: 2008-07-01 to 2009-06-30 Values: Latest reported Published: 2026-11-02T13:52:57Z Snapshot: 6e48cb0be5d9575d2554fd60dbaa21a5c42a4f9600280aff0f4b9cbb3bef2770 Dimensions: Consolidated View: https://fundies.io/companies/edgar/736994/explain?concept=fundies%3AOperatingCashFlow&period=2009-06-30&surface=latest&period_type=duration&start=2008-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 31000 USD (2008-07-01 to 2009-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/736994/0001019687-10-001960.txt#4680 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

68 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000736994, 736994, edgar:736994

Also known as ALLIANCE PHARMACEUTICAL CORP

ALLIANCE PHARMACEUTICAL CORP.

Trailing twelve months

Net income

Operating cash flow

Capital expenditure

Company performance

What changed year over year

Net income

Operating cash flow

Where revenue goes

Growth

Profit and cash

Balance sheet

Cash generation